Expression of M3 muscarinic acetylcholine receptors in gastric cancer
- PMID: 35673819
- PMCID: PMC9289715
- DOI: 10.47162/RJME.62.4.12
Expression of M3 muscarinic acetylcholine receptors in gastric cancer
Abstract
Introduction: Gastric cancer represents a real public health problem as far as incidence, aggressiveness and unfavorable prognosis are concerned. The autonomous nervous system might be one of the major factors involved in the onset, progression, and metastasis, both sympathetically and parasympathetically. The increased activation of the M3 muscarinic acetylcholine receptors (mAChRs) triggers pro-oncogenic mechanisms, especially at a gastric level, through the activation of the Hippo signaling pathway and the increase of the nerve growth factor.
Patients, materials and methods: In this study, biopsy or postoperative gastric resection pieces have been evaluated by histopathological (HP) and immunohistochemical (IHC) examination in a group of 77 gastric patients and 23 patients without an oncological diagnosis. To quantify the IHC signal, also considering the HP aspect, light microscopy images were obtained.
Results: The M3 mAChR expression analysis has been correlated with the different gastric adenocarcinoma differentiation degrees (G1-G3). M3 mAChR presence has been observed also in the non-malignant gastric tissue, but it was significantly increased in the tumor tissue. The highest receptor expression was recorded in patients with a poorly-differentiated (G3) adenocarcinoma, these expressions decreasing with the increase of the differentiation degree towards moderately-differentiated (G2) and well-differentiated (G1).
Conclusions: Surgical or pharmacological parasympathetic activity inhibition could decrease the development and progression of gastric tumors and could improve the gastric cancer patient's prognosis.
Conflict of interest statement
The authors declare that they have no conflict of interests.
Figures







Similar articles
-
Muscarinic acetylcholine receptor M3 in proliferation and perineural invasion of cholangiocarcinoma cells.Hepatobiliary Pancreat Dis Int. 2012 Aug 15;11(4):418-23. doi: 10.1016/s1499-3872(12)60201-x. Hepatobiliary Pancreat Dis Int. 2012. PMID: 22893470
-
Muscarinic M3 acetylcholine receptor immunostaining in paraffin-embedded normal and neoplastic prostatic gland tissue.Ann Diagn Pathol. 2004 Dec;8(6):333-6. doi: 10.1053/j.anndiagpath.2004.08.002. Ann Diagn Pathol. 2004. PMID: 15614736
-
Muscarinic receptor M3 mediates cell proliferation induced by acetylcholine and contributes to apoptosis in gastric cancer.Tumour Biol. 2016 Feb;37(2):2105-17. doi: 10.1007/s13277-015-4011-0. Epub 2015 Sep 7. Tumour Biol. 2016. PMID: 26346168
-
Function of cardiac M3 receptors.Auton Autacoid Pharmacol. 2007 Jan;27(1):1-11. doi: 10.1111/j.1474-8673.2006.00381.x. Auton Autacoid Pharmacol. 2007. PMID: 17199870 Review.
-
The Role of Muscarinic Acetylcholine Receptor M3 in Cardiovascular Diseases.Int J Mol Sci. 2024 Jul 10;25(14):7560. doi: 10.3390/ijms25147560. Int J Mol Sci. 2024. PMID: 39062802 Free PMC article. Review.
Cited by
-
Acetylcholine, Another Factor in Breast Cancer.Biology (Basel). 2023 Nov 11;12(11):1418. doi: 10.3390/biology12111418. Biology (Basel). 2023. PMID: 37998017 Free PMC article.
References
-
- Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–249. - PubMed
-
- Ferlay J, Ervik M, Lam F, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F, editors. Global Cancer Observatory cancer today. Lyon France: International Agency for Research on Cancer (IARC; 2020. https://gco.iarc.fr/today
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous